These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30753336)

  • 21.
    Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient-derived functional organoids as a personalized approach for drug screening against hepatobiliary cancers.
    Li L; Selaru FM
    Adv Cancer Res; 2022; 156():319-341. PubMed ID: 35961704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
    Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
    Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An organoid-based carcinogenesis model induced by in vitro chemical treatment.
    Naruse M; Masui R; Ochiai M; Maru Y; Hippo Y; Imai T
    Carcinogenesis; 2020 Oct; 41(10):1444-1453. PubMed ID: 32047892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
    Shiota J; Samuelson LC; Razumilava N
    Hepatology; 2021 Oct; 74(4):2251-2263. PubMed ID: 33638203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma.
    DeLeon TT; Ahn DH; Bogenberger JM; Anastasiadis PZ; Arora M; Ramanathan RK; Aqel BA; Vasmatzis G; Truty MJ; Oklu R; Bekaii-Saab TS; Borad MJ
    Future Oncol; 2018 Mar; 14(6):553-566. PubMed ID: 29460642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer
    Saborowski A; Wolff K; Spielberg S; Beer B; Hartleben B; Erlangga Z; Becker D; Dow LE; Marhenke S; Woller N; Unger K; Schirmacher P; Manns MP; Marquardt JU; Vogel A; Saborowski M
    Hepatol Commun; 2019 Mar; 3(3):423-436. PubMed ID: 30859153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives.
    Maru Y; Hippo Y
    Front Genet; 2021; 12():798628. PubMed ID: 34956336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics.
    Voutsadakis IA
    Crit Rev Oncol Hematol; 2023 Jun; 186():103987. PubMed ID: 37059275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics of biliary tract cancer.
    Sohal DP; Shrotriya S; Abazeed M; Cruise M; Khorana A
    Crit Rev Oncol Hematol; 2016 Nov; 107():111-118. PubMed ID: 27823638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs).
    Wu X; Li Z; Zhang H; He F; Qiao M; Luo H; Zhang J; Zhang M; Mao Y; Wagstaff W; Zhang Y; Niu C; Zhao X; Wang H; Huang L; Shi D; Liu Q; Ni N; Fu K; Haydon RC; Reid RR; Luu HH; He TC; Wang Z; Liang H; Zhang BQ; Wang N
    Genes Dis; 2021 Nov; 8(6):814-826. PubMed ID: 34522710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent Activation of Kras and Canonical Wnt Signaling Induces Premalignant Lesions That Progress to Extrahepatic Biliary Cancer in Mice.
    Nagao M; Fukuda A; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Araki O; Yoshikawa T; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Taketo MM; Ferrer J; Tsuruyama T; Nakanuma Y; Taura K; Uemoto S; Seno H
    Cancer Res; 2022 May; 82(9):1803-1817. PubMed ID: 35247892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
    Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs.
    Harada K; Sato Y; Ikeda H; Maylee H; Igarashi S; Okamura A; Masuda S; Nakanuma Y
    Virchows Arch; 2012 Mar; 460(3):281-9. PubMed ID: 22358181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-associated fibroblasts nurture LGR5 marked liver tumor-initiating cells and promote their tumor formation, growth, and metastasis.
    Zhang M; Fang Y; Fu X; Liu J; Liu Y; Zhu Z; Ni Y; Yao M; Pan Q; Cao W; Li Z; Dong C
    Cancer Med; 2023 Sep; 12(17):18032-18049. PubMed ID: 37578396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesis.
    Schuster K; Venkateswaran N; Rabellino A; Girard L; Peña-Llopis S; Scaglioni PP
    Mol Cancer Res; 2014 Jun; 12(6):912-23. PubMed ID: 24618618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and Culture of Tumor and Metastatic Organoids from Murine Models of Pancreatic Ductal Adenocarcinoma.
    Baker LA; Tuveson DA
    Methods Mol Biol; 2019; 1882():117-133. PubMed ID: 30378048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice.
    Izumiya M; Kato S; Hippo Y
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
    Berchuck JE; Facchinetti F; DiToro DF; Baiev I; Majeed U; Reyes S; Chen C; Zhang K; Sharman R; Uson Junior PLS; Maurer J; Shroff RT; Pritchard CC; Wu MJ; Catenacci DVT; Javle M; Friboulet L; Hollebecque A; Bardeesy N; Zhu AX; Lennerz JK; Tan B; Borad M; Parikh AR; Kiedrowski LA; Kelley RK; Mody K; Juric D; Goyal L
    Ann Oncol; 2022 Dec; 33(12):1269-1283. PubMed ID: 36089135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.